Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Mantle-Cell 66Lymphoma 65Lymphoma, Non-Hodgkin 43Lymphoma, Follicular 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 41Lymphoma, Large B-Cell, Diffuse 34Waldenstrom Macroglobulinemia 33Lymphoma, B-Cell, Marginal Zone 30Leukemia, Lymphocytic, Chronic, B-Cell 28Recurrence 18Multiple Myeloma 17Hodgkin Disease 17Lymphoma, B-Cell 14Leukemia, Myeloid, Acute 14Burkitt Lymphoma 14Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma, Large-Cell, Anaplastic 13Leukemia 12Immunoblastic Lymphadenopathy 12Mycosis Fungoides 11Lymphoma, T-Cell, Cutaneous 11Lymphoma, Large-Cell, Immunoblastic 11Sezary Syndrome 10Lymphoma, T-Cell, Peripheral 10Neoplasms, Plasma Cell 9Neoplasms 9Lymphoma, T-Cell 8Myelodysplastic Syndromes 7Lymphoma, Extranodal NK-T-Cell 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6

Interventions

Vincristine 2Rituximab 2Prednisone 2Doxorubicin 2Cyclophosphamide 2pevonedistat 1Filgrastim 1Etoposide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acromesomelic dysplasia, Maroteaux type × Bortezomib × Lymphoid × Clear all
NCT00931918 2017-01-11

Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients

Takeda

Phase 2 Completed
206 enrolled 18 charts
Lymphoid

Acromesomelic dysplasia, Maroteaux type, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡